These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31370110)

  • 41. Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit.
    Enomoto T; Lu HQ; Yin M; Sakoda T; Dake Y; Enomoto K; Ide T; Cheng L
    J Investig Allergol Clin Immunol; 2009; 19(4):299-305. PubMed ID: 19639726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Number of seasonal exposures to Japanese cedar pollen increases the risk of sensitization: Observational study in Korean adults.
    Suh MJ; Yi HJ; Kim JH; Lee KH; Hong SC; Kang JW
    Sci Rep; 2019 Jul; 9(1):10496. PubMed ID: 31324893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The occurrence of Japanese cedar pollinosis with rheumatoid arthritis.
    Koizumi K; Okamoto H; Kamitsuji S; Sato E; Suzuki K; Yamanaka H; Hara M; Tomatsu T; Kamatani N
    Clin Exp Rheumatol; 2007; 25(3):505-6. PubMed ID: 17631756
    [No Abstract]   [Full Text] [Related]  

  • 44. [Practical guideline for allergic rhinitis 2014 (7th edition): points of revision -prophylactic treatment for cedar pollinosis-].
    Okamoto Y
    Arerugi; 2014 Nov; 63(9):1216-22. PubMed ID: 25492876
    [No Abstract]   [Full Text] [Related]  

  • 45. [A novel murine model of Japanese cedar pollinosis for characterizing allergen-specific sublingual immunotherapy].
    Tofukuji S; Ishida S; Katayama K
    Nihon Yakurigaku Zasshi; 2017; 150(2):68-71. PubMed ID: 28794300
    [No Abstract]   [Full Text] [Related]  

  • 46. Japanese Cedar Pollen-Specific IgA in Nasal Secretions and Nasal Allergy Symptoms.
    Suzuki M; Yokota M; Ozaki S; Matsumoto T; Nakamura Y
    Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):330-337. PubMed ID: 30678469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced production of IgE anti-Japanese cedar pollen specific antibodies by peripheral blood B cells from patients with Japanese cedar pollinosis.
    Ohshima N; Hirohata S
    Allergol Int; 2008 Jun; 57(2):147-55. PubMed ID: 18349589
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunodominance in allergic T-cell reactivity to Japanese cedar in different geographic cohorts.
    Oseroff C; Pham J; Frazier A; Hinz D; Sidney J; Paul S; Greenbaum JA; Vita R; Peters B; Schulten V; Sette A
    Ann Allergy Asthma Immunol; 2016 Dec; 117(6):680-689.e1. PubMed ID: 27979027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An analysis of factors associated with compliance and dropout of sublingual immunotherapy on Japanese cedar pollinosis patients.
    Imanaka T; Sato I; Kawasaki Y; Kanazawa Y; Kawakami K
    Int Forum Allergy Rhinol; 2019 Jun; 9(6):615-623. PubMed ID: 31173675
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term immunological effects of Japanese cedar pollen-based subcutaneous immunotherapy.
    Inuo C; Ando H; Tanaka K; Nakajima Y; Tsuge I; Urisu A; Kondo Y
    Allergol Int; 2018 Jul; 67(3):408-410. PubMed ID: 29198713
    [No Abstract]   [Full Text] [Related]  

  • 51. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K; Gotoh M
    Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prophylactic effect of Lactobacillus oral vaccine expressing a Japanese cedar pollen allergen.
    Ohkouchi K; Kawamoto S; Tatsugawa K; Yoshikawa N; Takaoka Y; Miyauchi S; Aki T; Yamashita M; Murooka Y; Ono K
    J Biosci Bioeng; 2012 Apr; 113(4):536-41. PubMed ID: 22196937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells.
    Masuda K
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):185-7. PubMed ID: 16098609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preliminary Clinical Trial of Biomarkers to Predict Response to Sublingual Immunotherapy for Japanese Cedar Pollinosis.
    Takahara E; Matsune S; Ishida M; Wakayama N; Okubo K
    J Nippon Med Sch; 2020 Dec; 87(5):277-284. PubMed ID: 32074537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Noninvasive biological evaluation of response to pranlukast treatment in pediatric patients with Japanese cedar pollinosis.
    Gotoh M; Okubo K; Hashiguchi K; Wakabayashi K; Kanzaki S; Tanaka N; Fujioka M; Kawashima K; Suematsu K; Sasaki K; Iwasaki M; Yamamotoya H
    Allergy Asthma Proc; 2012; 33(6):459-66. PubMed ID: 23394502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early interventional treatment with intranasal corticosteroids compared with postonset treatment in pollinosis.
    Higaki T; Okano M; Makihara S; Fujiwara T; Haruna T; Noda Y; Kariya S; Nishizaki K
    Ann Allergy Asthma Immunol; 2012 Dec; 109(6):458-64. PubMed ID: 23176888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of daily intake of Lactobacillus paracasei strain KW3110 on Japanese cedar pollinosis.
    Yonekura S; Okamoto Y; Okawa T; Hisamitsu M; Chazono H; Kobayashi K; Sakurai D; Horiguchi S; Hanazawa T
    Allergy Asthma Proc; 2009; 30(4):397-405. PubMed ID: 19772761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of oral administration of a heat-killed Lactobacillus gasseri OLL2809 on patients of Japanese cedar pollinosis with high Japanese-cedar pollen-specific IgE.
    Gotoh M; Sashihara T; Ikegami S; Yamaji T; Kino K; Orii N; Taketomo N; Okubo K
    Biosci Biotechnol Biochem; 2009 Sep; 73(9):1971-7. PubMed ID: 19734682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of intranasal corticosteroid on pre-onset activation of eosinophils and mast cells in experimental Japanese cedar pollinosis.
    Noyama Y; Okano M; Fujiwara T; Kariya S; Makihara S; Haruna T; Kanai K; Higaki T; Nishizaki K
    Allergol Int; 2016 Jul; 65(3):259-65. PubMed ID: 26907728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract.
    Kawakami A; Koketsu R; Suzukawa M; Nagao M; Hiraguchi Y; Tokuda R; Fujisawa T; Nagase H; Ohta K; Yamamoto K; Yamaguchi M
    Int Arch Allergy Immunol; 2008; 146 Suppl 1():54-60. PubMed ID: 18504408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.